IGF1 and type 1 diabetes mellitus: The latter is proven in a study of pancreas-transplanted T1DM patients; specifically, patients with portal-vein drainage grafts exhibit higher IGF-1 and lower GH levels than those with systemic-vein drainage grafts [101].